Activation of coagulation factor X in human semen

Steven D Carson, Christopher J. De Jonge

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Tissue factor (TF) is an essential cofactor for factor VII (fVII) in initiating blood coagulation. Recently, TF was shown to be present in human semen and to be associated with prostasomes that originate from prostatic secretions. In the blood coagulation cascade, the complex of TF and activated factor VII (fVIIa) can activate both factor X and factor IX, by limited proteolysis. In the present study, we investigated the ability of semen to activate factor X. We also determined that factor X was activated predominantly by TF-fVIIa and that most of the TF was present in the seminal plasma, consistent with prostasome localization. No endogenous factor X was detected in semen, but activation of added factor X occurred in the absence of added fVIIa. Subsequent experiments showed that seminal plasma contains endogenous fVII-like activity, but the addition of more fVIIa increased factor X activation. Thus, while seminal plasma contains significant amounts of TF, its potential to activate factor X is limited by fVII availability and by the absence of endogenous factor X. Evaluation of semen specimens from infertility patients revealed a 16-fold variation in TF-fVII activity. No relationship between TF and number of days of abstinence, specimen pH, sperm count, or sperm motility was evident. Additional factor X-activating potential, independent of further TF activity, was generated in seminal plasma after treatment of semen with calcium and ionophore A23187. Production of this additional activity was blocked by the addition of anti-TF antibody during the activation. Since there is no factor X endogenous to semen, the additional activity stimulated by A23187 appears to be due to an endogenous, non-factor X substrate for TF-fVII in semen. This endogenous substrate may be either factor IX or a novel new substrate for TF-fVIIa. Future experiments will test these hypotheses.

Original languageEnglish (US)
Pages (from-to)289-294
Number of pages6
JournalJournal of Andrology
Volume19
Issue number3
StatePublished - May 1 1998

Fingerprint

Factor X
Thromboplastin
Semen
Factor VII
Factor IX
Calcimycin
Blood Coagulation
Factor VIIa
Factor Xa
Sperm Count
Calcium Ionophores
Sperm Motility
Infertility
Proteolysis

Keywords

  • Blood clotting
  • Factor VII
  • Hemostasis
  • Tissue factor

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Reproductive Medicine
  • Endocrinology
  • Urology

Cite this

Activation of coagulation factor X in human semen. / Carson, Steven D; De Jonge, Christopher J.

In: Journal of Andrology, Vol. 19, No. 3, 01.05.1998, p. 289-294.

Research output: Contribution to journalArticle

Carson, SD & De Jonge, CJ 1998, 'Activation of coagulation factor X in human semen', Journal of Andrology, vol. 19, no. 3, pp. 289-294.
Carson, Steven D ; De Jonge, Christopher J. / Activation of coagulation factor X in human semen. In: Journal of Andrology. 1998 ; Vol. 19, No. 3. pp. 289-294.
@article{fd11ca8703b0449b90f8f3795dd618c6,
title = "Activation of coagulation factor X in human semen",
abstract = "Tissue factor (TF) is an essential cofactor for factor VII (fVII) in initiating blood coagulation. Recently, TF was shown to be present in human semen and to be associated with prostasomes that originate from prostatic secretions. In the blood coagulation cascade, the complex of TF and activated factor VII (fVIIa) can activate both factor X and factor IX, by limited proteolysis. In the present study, we investigated the ability of semen to activate factor X. We also determined that factor X was activated predominantly by TF-fVIIa and that most of the TF was present in the seminal plasma, consistent with prostasome localization. No endogenous factor X was detected in semen, but activation of added factor X occurred in the absence of added fVIIa. Subsequent experiments showed that seminal plasma contains endogenous fVII-like activity, but the addition of more fVIIa increased factor X activation. Thus, while seminal plasma contains significant amounts of TF, its potential to activate factor X is limited by fVII availability and by the absence of endogenous factor X. Evaluation of semen specimens from infertility patients revealed a 16-fold variation in TF-fVII activity. No relationship between TF and number of days of abstinence, specimen pH, sperm count, or sperm motility was evident. Additional factor X-activating potential, independent of further TF activity, was generated in seminal plasma after treatment of semen with calcium and ionophore A23187. Production of this additional activity was blocked by the addition of anti-TF antibody during the activation. Since there is no factor X endogenous to semen, the additional activity stimulated by A23187 appears to be due to an endogenous, non-factor X substrate for TF-fVII in semen. This endogenous substrate may be either factor IX or a novel new substrate for TF-fVIIa. Future experiments will test these hypotheses.",
keywords = "Blood clotting, Factor VII, Hemostasis, Tissue factor",
author = "Carson, {Steven D} and {De Jonge}, {Christopher J.}",
year = "1998",
month = "5",
day = "1",
language = "English (US)",
volume = "19",
pages = "289--294",
journal = "Journal of Andrology",
issn = "0196-3635",
publisher = "American Society of Andrology Inc.",
number = "3",

}

TY - JOUR

T1 - Activation of coagulation factor X in human semen

AU - Carson, Steven D

AU - De Jonge, Christopher J.

PY - 1998/5/1

Y1 - 1998/5/1

N2 - Tissue factor (TF) is an essential cofactor for factor VII (fVII) in initiating blood coagulation. Recently, TF was shown to be present in human semen and to be associated with prostasomes that originate from prostatic secretions. In the blood coagulation cascade, the complex of TF and activated factor VII (fVIIa) can activate both factor X and factor IX, by limited proteolysis. In the present study, we investigated the ability of semen to activate factor X. We also determined that factor X was activated predominantly by TF-fVIIa and that most of the TF was present in the seminal plasma, consistent with prostasome localization. No endogenous factor X was detected in semen, but activation of added factor X occurred in the absence of added fVIIa. Subsequent experiments showed that seminal plasma contains endogenous fVII-like activity, but the addition of more fVIIa increased factor X activation. Thus, while seminal plasma contains significant amounts of TF, its potential to activate factor X is limited by fVII availability and by the absence of endogenous factor X. Evaluation of semen specimens from infertility patients revealed a 16-fold variation in TF-fVII activity. No relationship between TF and number of days of abstinence, specimen pH, sperm count, or sperm motility was evident. Additional factor X-activating potential, independent of further TF activity, was generated in seminal plasma after treatment of semen with calcium and ionophore A23187. Production of this additional activity was blocked by the addition of anti-TF antibody during the activation. Since there is no factor X endogenous to semen, the additional activity stimulated by A23187 appears to be due to an endogenous, non-factor X substrate for TF-fVII in semen. This endogenous substrate may be either factor IX or a novel new substrate for TF-fVIIa. Future experiments will test these hypotheses.

AB - Tissue factor (TF) is an essential cofactor for factor VII (fVII) in initiating blood coagulation. Recently, TF was shown to be present in human semen and to be associated with prostasomes that originate from prostatic secretions. In the blood coagulation cascade, the complex of TF and activated factor VII (fVIIa) can activate both factor X and factor IX, by limited proteolysis. In the present study, we investigated the ability of semen to activate factor X. We also determined that factor X was activated predominantly by TF-fVIIa and that most of the TF was present in the seminal plasma, consistent with prostasome localization. No endogenous factor X was detected in semen, but activation of added factor X occurred in the absence of added fVIIa. Subsequent experiments showed that seminal plasma contains endogenous fVII-like activity, but the addition of more fVIIa increased factor X activation. Thus, while seminal plasma contains significant amounts of TF, its potential to activate factor X is limited by fVII availability and by the absence of endogenous factor X. Evaluation of semen specimens from infertility patients revealed a 16-fold variation in TF-fVII activity. No relationship between TF and number of days of abstinence, specimen pH, sperm count, or sperm motility was evident. Additional factor X-activating potential, independent of further TF activity, was generated in seminal plasma after treatment of semen with calcium and ionophore A23187. Production of this additional activity was blocked by the addition of anti-TF antibody during the activation. Since there is no factor X endogenous to semen, the additional activity stimulated by A23187 appears to be due to an endogenous, non-factor X substrate for TF-fVII in semen. This endogenous substrate may be either factor IX or a novel new substrate for TF-fVIIa. Future experiments will test these hypotheses.

KW - Blood clotting

KW - Factor VII

KW - Hemostasis

KW - Tissue factor

UR - http://www.scopus.com/inward/record.url?scp=0031747748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031747748&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 289

EP - 294

JO - Journal of Andrology

JF - Journal of Andrology

SN - 0196-3635

IS - 3

ER -